ORTEXORTEX News
Tracking HTZ? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HT
Trader NoteHTZ

HTZ Bears Dig In at 32.6% Short Interest — Barclays Cuts Target to $1

By ORTEX News · Edited by , Editor, ORTEX News3 min readdata as of 28 Jul 2026, 17:25

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Hertz Global Holdings heads into its August 6 earnings print with the short book at a new cycle high, Barclays slashing its target to match the current stock price, and the borrow market locked shut for a fifth consecutive week.

The short interest story has another chapter this week. Shares short rose to 101.7 million — 32.6% of free float — the highest reading in this cycle. That is up 13% on the week and has nearly doubled since mid-June. The ORTEX short score holds at 76.2, its highest in the recent series and a reading that places Hertz in the bottom 4% of all tracked names globally. Bears built through the week rather than trimmed heading into a known catalyst date, which is the more notable point.

The lending market remains completely seized. Availability has been pinned at 0% without interruption since late June — every share in the borrow pool is lent out, the tightest condition in the 52-week range. Borrow costs, by contrast, have settled: the rate is now running at 1.54%, down more than 75% from the early-July spike above 5%. That divergence — maximum borrow stress on availability, but easing cost — reflects a market where existing shorts are holding positions rather than new money racing to add. The put/call ratio at 1.33 is almost exactly in line with its 20-day average, suggesting options traders have not shifted markedly more defensive ahead of the print.

The Street has moved decisively more negative this week. Barclays cut its target from $3 to $1 this morning — exactly where the stock trades — while maintaining its Underweight. Goldman Sachs moved earlier in the week, cutting from $3 to $2, also maintaining its Sell. Morgan Stanley trimmed to $3.50 from $5 at end of June. Three bellwether firms, three target cuts, zero upgrades in the recent window. The consensus mean target is $3.44, but that figure is dragged up by the Susquehanna Neutral at $5.50 — a May print that looks increasingly stale against the current tape. On valuation, the EV/EBITDA multiple has expanded to 43x despite a negative earnings yield, a combination that reflects the debt load rather than equity optionality. The company scores in the 87th percentile on EPS surprise historically, but ranks in just the 2nd percentile on EV/EBIT — a stark signal of how much the capital structure dominates the investment case.

Insider activity adds context. The CFO sold $724,000 worth of stock in mid-June at $4.83, the COO sold $722,000 days later at $5.13, and the CEO sold $1.3 million in April at $5.18. The pattern is consistent and directional: every recent transaction in the past 90 days has been a sale, totalling just over $2 million in net proceeds. None of the insiders has bought at sub-$2 levels, even as the stock collapsed from those sale prices.

The prior earnings print in May delivered a 6.6% drop on day one and a further 10% over the following five days — the closest historical read on what a weak result could mean in this setup. The August 6 release is the next moment that matters: with the short book at a record, the borrow market fully deployed, and the two loudest bears on the Street now targeting $1-$2, the question is whether the print gives either side a reason to move.

Stocks in this article

See the live data behind this article on ORTEX.

Open HTZ on ORTEX →

How this article was generated

Generated
28 Jul 2026, 17:33
Data as of
28 Jul 2026, 17:25
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.